Joseph Truitt is Director of Larimar Therapeutics, Inc.. Currently has a direct ownership of 2,750 shares of LRMR, which is worth approximately $17,132. The most recent transaction as insider was on May 17, 2023, when has been sold 2,750 shares (Common Stock) at a price of $3.73 per share, resulting in proceeds of $10,257. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.75K
0% 3M change
0% 12M change
Total Value Held $17,132

Joseph Truitt Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2023
BUY
Open market or private purchase
$10,257 $3.73 p/Share
2,750 Added 50.0%
2,750 Common Stock
JT

Joseph Truitt

Director
Bala Cynwyd, PA

Track Institutional and Insider Activities on LRMR

Follow Larimar Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LRMR shares.

Notify only if

Insider Trading

Get notified when an Larimar Therapeutics, Inc. insider buys or sells LRMR shares.

Notify only if

News

Receive news related to Larimar Therapeutics, Inc.

Track Activities on LRMR